Cargando…
A Novel Risk-Score Model With Eight MiRNA Signatures for Overall Survival of Patients With Lung Adenocarcinoma
Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer with heterogeneous outcomes and diverse therapeutic responses. To classify patients into different groups and facilitate the suitable therapeutic strategy, we first selected eight microRNA (miRNA) signatures in The Cancer Genome At...
Autores principales: | Wu, Jun, Lou, Yuqing, Ma, Yi-Min, Xu, Jun, Shi, Tieliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633443/ https://www.ncbi.nlm.nih.gov/pubmed/34868213 http://dx.doi.org/10.3389/fgene.2021.741112 |
Ejemplares similares
-
An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma
por: Li, Xuelian, et al.
Publicado: (2014) -
A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022) -
Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022) -
Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma
por: Li, Tingting, et al.
Publicado: (2022) -
Establishment and Validation of a Ferroptosis-Related Gene Signature to Predict Overall Survival in Lung Adenocarcinoma
por: Wang, Su, et al.
Publicado: (2022)